Hereditary Hemorrhagic Telangiectasia (HHT) Center

Key Facts

Status: Open

Posted date: March 16, 2026

Archive date: July 1, 2026

Opportunity ID: 361511

Opportunity number: HRSA-26-092

Opportunity category: Discretionary

Agency name: Health Resources and Services Administration

Agency code: HHS-HRSA

Award floor: $0

Award ceiling: $2,900,000

Cost sharing required: No

Funding Instrument Types
  • Cooperative Agreement
Category of Funding Activity
  • Health
Eligible Applicants
  • State governments
  • Unrestricted
Tools
Categories (use these for quoted searches)
  • agency_code:hhs_hrsa
  • category_of_funding_activity:health
  • cost_sharing_or_matching_requirement:false
  • eligible_applicants:state_governments
  • eligible_applicants:unrestricted
  • funding_instrument_type:cooperative_agreement
  • opportunity_category:discretionary
  • status:open
Description

The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) Center Program is to reduce illness and death related to HHT by partnering with clinical center to expand access and coordination of care; creating innovative strategies that support clinicians with identifying and diagnosing HHT cases; and developing a de-identified, aggregate patient data registry to better understand this rare disease and its treatment outcomes.

Hereditary Hemorrhagic Telangiectasia (HHT) Center
The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) Center Program is to reduce illness and death related to HHT by partnering with clinical center to expand access and coordination of care; creating innovative strategies that support clinicians with identifying and diagnosing HHT cases; and developing a de-identified, aggregate patient data registry to better understand this rare disease and its treatment outcomes.
Hereditary Hemorrhagic Telangiectasia (HHT) Center
Open
Health Resources and Services Administration
Health
Cooperative Agreement
State governments
Unrestricted
2026-03-16